Andrea Piacquadio
© Credits

Influenza (seasonal)

    Overview

    Seasonal influenza is an acute respiratory infection caused by influenza viruses which circulate in all parts of the world. It represents a year-round disease burden. It causes illnesses that range in severity and sometimes lead to hospitalization and death.

    Most people recover from fever and other symptoms within a week without requiring medical attention. However, influenza can cause severe illness or death, particularly among high risk groups including the very young, the elderly, pregnant women, health workers and those with serious medical conditions.

    In temperate climates, seasonal epidemics occur mainly during winter, while in tropical regions, influenza may occur throughout the year, causing outbreaks more irregularly.

    Symptoms

    Seasonal influenza is characterized by a sudden onset of fever, cough (usually dry), headache, muscle and joint pain, severe malaise (feeling unwell), sore throat and a runny nose. The cough can be severe and can last two or more weeks.

    Treatment

    For patients that are not in a high risk group, treatment focuses on relieving symptoms of influenza such as fever. Patients that are known to be in a group at high risk for developing severe or complicated illness should seek medical attention and should be treated with antiviral drug as soon as possible.

    News

    All →

    Publications

    All →
    Improved influenza vaccines: full value vaccine assessment

    Seasonal influenza remains a major global public health challenge, causing substantial morbidity and mortality each year. The World Health Organization...

    WHO guidance on the use of licensed human influenza A(H5) vaccines for the interpandemic and emergence periods

    This WHO guidance document outlines the primary objectives for the use of licensed human A(H5) vaccines for the interpandemic and emergence periods, identifies...

    WHO preferred product characteristics for next generation influenza vaccines, second edition

    In 2017, WHO published Preferred Product Characteristics (PPCs) to guide the development of next-generation influenza vaccines, and to encourage innovation...

    Public health resource pack for countries experiencing outbreaks of influenza in animals: revised guidance

    This resource pack was developed for the country offices of the World Health Organization and national Public Health institutions, as an overview of the...